PharmaBoardroom

Carl Firth – CEO, ASLAN Pharmaceuticals

ASLAN Pharmaceuticals is a clinical-stage immunology-focused biopharmaceutical company. CEO Dr Carl Firth reveals why the company has shifted its…

ISREC’s Susan Gasser: A “Hard-Nosed” Approach to Research…

After 15 years as director at the Friedrich Miescher Institute for Biomedical Research (FMI) (2004-2019) and even longer as the group leader at her…

Mexico: US Vaccine Tourism; CanSino Stepping Up; AMLO Calls for…

The latest from Mexico’s fight against COVID-19, including news of vaccine tourism into the US, how China’s CanSino is filling the gaps left by…

Marc-Olivier Geinoz – CEO, Dipharma SA

Dipharma SA is a Swiss specialty pharmaceutical company, developing improved generics medicines for rare metabolic diseases. Founder & CEO…

HSA: APAC’s Regulatory Gold Standard

As the most important pharma hub in its region, and one of the most important globally, many companies look to launch new products in Singapore first…

5 Things to Know about Saudi Arabian Pharma

A rundown of five things to know about the USD 8.2 billion Saudi pharma market, including the impact of ‘Vision 2030’, the country’s leading…

China: Yangtze River Pharmaceutical Group (YRPG) in Profile

One of the largest domestic pharma companies in China (ranking number one from 2014 to 2019), Yangtze River Pharmaceutical Group (YRPG) is so-named…

Choong May Ling, Mimi – CEO, Health Sciences Authority (HSA),…

Dr Choong May Ling, Mimi, CEO of Singapore’s Health Sciences Authority (HSA), one of the leading regulatory bodies in the Asia-Pacific region,…

Lorenzo Ambrosini – CEO, Agire Foundation, Switzerland

Lorenzo Ambrosini of the Agire Foundation introduces the major new innovation projects underway in the Italian-speaking Swiss canton of Ticino; the…

Medtech’s Post-COVID Paradigm in APAC

At USD 150 billion, Asia-Pacific is home to the world’s second largest medtech market and, with a CAGR of nine percent, certainly its most dynamic.…

MEA: Pfizer’s Saudi Transformation; Urgent Call for Arab Import…

The latest news from Middle East & North African pharma, including Pfizer’s transformation of its Saudi operations; why India is calling for…

New Drug Approvals in China 2020

The Chinese NMPA’s drug approval list for 2020 includes a surge in approvals for locally developed drugs. A total of 46 new drugs were approved in…

Tagged with R